Thank you for downloading this publication. Please let us know why you chose this publication:
Why are you interested in this publication?
What organisation do you represent?
You will only need to complete this form once per browser/device
How do you prefer to read or receive publications?

We may contact you for feedback on the publication you have downloaded. If you do not want to be contacted, please leave the email field blank. Your information will never be shared with any third party.

Malaria Consortium US Donate
  • About us
    • Who we are
    • Our Strategy
    • Governance
    • Aid transparency
  • Projects
  • Where We Work
  • What we do
    • Diseases
    • Our responses
    • Burden reduction to elimination
    • Data-informed decision-making & digital approaches
    • Health sector resilience
    • Research & policy change
    • Networks & partnerships
  • News & Resources
    • News
    • Blog
    • Videos
    • Webinars
    • Photo stories
  • Publications
    • Interactive publications
  • Support us
  • Contact Us
  • Work with us
    • Tenders
  • Home
  • »
  • Resources
  • »
  • Publications
  • »
  • Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting

Share this page

Resources

Latest

Publications

Publication Date:
19/12/2012

Type:
Journal article
Publication

Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting
Author(s): WHO Malaria Policy Advisory Committee and Secretariat

Publication Date:
19/12/2012
Type:
Journal article

The Malaria Policy Advisory Committee to the World Health Organization met in Geneva, Switzerland from 11 to 13 September, 2012. This article provides a summary of the discussions, conclusions and recommendations from that meeting.

Meeting sessions included: updated policy recommendations on the use of sulphadoxinepyrimethamine for Intermittent Preventive Treatment of malaria in pregnancy, as well as the use of single dose primaquine as a Plasmodium falciparum gametocytocide; the need to develop a Global Technical Strategy for Malaria Control and Elimination 2016– 2025 and a global strategy for control of Plasmodium vivax; the Affordable Medicines Facility for malaria independent evaluation and promoting malaria case management in the private sector; updates from the Technical Expert Group on drug resistance and containment and the Evidence Review Group on malaria burden estimation; update on the RTS,S/AS01 malaria vaccine; progress on the policy setting process for malaria vector control; and the process for updating the WHO Guidelines for the Treatment of Malaria. Policy statements, position statements, and guidelines that arise from the MPAC meeting conclusions and recommendations will be formally issued and disseminated to World Health Organization Member States by the World Health Organization Global Malaria Programme.

Click here to download

Citation: WHO Malaria Policy Advisory Committee and Secretariat. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting. Malaria Journal 2012, 11:424 doi:10.1186/1475-2875-11-424

Keywords: WHO; Policy development; Sulphadoxine-pyrimethamine; Neonatal | maternal and child health; Prevention; Primaquine; Gametocytes; Plasmodium falciparum; Plasmodium vivax; Diagnosis; Drug resistance; Surveillance / disease surveillance

 

 

« Back to Publications

Sign up for our newsletter here:

Follow us on our social channels
  • Jobs
  • Contact us
  • Annual reviews
  • Support us
  • About us
  • Sitemap
  • Policies
  • Modern Slavery Statement
Fundraising Regulator logo
© 2022 Malaria Consortium | Charity No. 1099776 | Company No. 4785712